Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Relationship Between Infliximab Treatment Response, Regulatory T Cells, and Interleukin-2 in Crohn's Disease

NCT01266785 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01266785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01266785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Relationship Between Infliximab Treatment Response, Regulatory T Cells, and Interleukin-2 in Crohn's Disease
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2010
Completion date
July 31, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease